A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient Stephen R. Ash, Bhupinder Singh, Philip T. Lavin, Fiona Stavros, Henrik S. Rasmussen Kidney International Volume 88, Issue 2, Pages (August 2015) DOI: /ki Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 1 Kidney International , DOI: ( /ki ) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 2 Kidney International , DOI: ( /ki ) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 3 Kidney International , DOI: ( /ki ) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 4 Kidney International , DOI: ( /ki ) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 5 Kidney International , DOI: ( /ki ) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 6 Kidney International , DOI: ( /ki ) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions